AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 16511917
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cyclosporine (CSA) and leflunomide (LEF)
Trial: 3753754
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of 1,25(OH)2D3 treatment in five children
Trial: 16842480
Drug: Nateglinide plus
RxNorm normalized name: Nateglinide
DrugBank: Nateglinide (DB00731)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nateglinide plus metformin
Trial: 16842480
Drug: Gliclazide plus
RxNorm normalized name: gliclazide
DrugBank: Gliclazide (DB01120)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gliclazide plus metformin
Trial: 11453888
Drug: Dihydrocodeine (DHC)
RxNorm normalized name: chlorpheniramine / dihydrocodeine / phenylephrine Oral Solution [Tusscough DHC]
DrugBank: Dihydrocodeine (DB01551)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dihydrocodeine (DHC) 90 mg
Trial: 25047245
Drug: Problem-Solving Treatment
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-Solving Treatment
Trial: 11070746
Drug: Zafirlukast ('Accolate')
RxNorm normalized name: Zafirlukast
DrugBank: Zafirlukast (DB00549)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zafirlukast ('Accolate') 20 mg twice daily
Trial: 31706582
Drug: Hydrocortisone administration
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone administration
Trial: 24806747
Drug: Niaspan(®) (2 g/day)
RxNorm normalized name: Niaspan
DrugBank: Niacin (DB00627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niaspan(®) (2 g/day)
Trial: 1092444
Drug: Prophylactic antibiotic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotic therapy initiated preoperatively, with moderately high dosage for short periods.
Trial: 27984024
Drug: Topical antibiotics
RxNorm normalized name: Tetracycline and derivatives, topical antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical antibiotics
Trial: 21897336
Drug: Alcohol infusions
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol infusions combined with initial oral alcohol load up to a blood alcohol steady state of 100 mg/dL (healthy volunteers, n = 12)
Trial: 18452779
Drug: Conventional calcium-channel
RxNorm normalized name: Channel catfish
DrugBank: Channel catfish (DB15548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional calcium-channel blocker (CCB) therapy
Trial: 15378145
Drug: Colchicine administered
RxNorm normalized name: Colchicine
DrugBank: Colchicine (DB01394)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colchicine administered as a single daily dose (Group II)
Trial: 91023
Drug: A combination
RxNorm normalized name: Enema combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A combination of 50 mg acarbose and 14.5 g guar gum
Trial: 19029093
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg kg(‐1) bolus
Trial: 26929616
Drug: Telephone-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-delivered cognitive behavior therapy (CBT)
Trial: 23706546
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution (placebo)
Trial: 21316535
Drug: MF59-adjuvanted H5N1
RxNorm normalized name: Influenza A monovalent (H5N1), ADJUVANTED-2013
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted H5N1 influenza vaccine (7.5-μg doses) with a 2-week interval
Trial: 21316535
Drug: MF59-adjuvanted H5N1
RxNorm normalized name: Influenza A monovalent (H5N1), ADJUVANTED-2013
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF59-adjuvanted H5N1 influenza vaccine (7.5-μg doses) with a 3-week interval
Trial: 8150016
Drug: Medium-titre Edmonston-Zagreb
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-titre Edmonston-Zagreb (EZ) measles vaccine (10(4.6) p.f.u.)
Trial: 6825391
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg Asproclear
Trial: 6825391
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg compressed ASA
Trial: 31476451
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (2.5 g/day)
Trial: 23788270
Drug: Bevacizumab with
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab with irinotecan or temozolomide after 2 chemotherapy cycles (8 weeks)
Trial: 10754621
Drug: Crystalloid infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Crystalloid infusion at the same rates as group C
Trial: 8796792
Drug: 0.125 mg/2
RxNorm normalized name: digoxin 0.125 mg/2.5 mL (125 mcg/2.5 mL) (50 mcg/mL) ORAL SOLUTION, ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125 mg/2 ml PGE2 gel
Trial: 24130356
Drug: NPH insulin
RxNorm normalized name: NPH Insulin, Human 300 UNT per 3 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPH insulin
Trial: 3076707
Drug: Weekly antimalarial
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly antimalarial chemoprophylaxis (chloroquine)
Trial: 3709032
Drug: Tripelennamine HCl
RxNorm normalized name: tripelennamine HCl
DrugBank: Tripelennamine (DB00792)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tripelennamine HCl 50 mg
Trial: 3709032
Drug: Tripelennamine HCl
RxNorm normalized name: tripelennamine HCl
DrugBank: Tripelennamine (DB00792)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tripelennamine HCl 100 mg
Trial: 7028897
Drug: S-carboxymethylcysteine syrup
RxNorm normalized name: S-carboxymethylcysteine
DrugBank: Carbocisteine (DB04339)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-carboxymethylcysteine syrup (SCMC)
Trial: 19903345
Drug: Lifestyle intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lifestyle intervention consisting of three visits to a Personal Vitality Coach (PVC) and a Vitality Exercise Programme (VEP) over 6 months, including weekly guided yoga and aerobic workout sessions, and encouragement for vigorous physical activity.
Trial: 2807448
Drug: Oral rehydration
RxNorm normalized name: Oral rehydration salt formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral rehydration therapy (ORT) introduced by health volunteers
Trial: 23756962
Drug: Toltrazuril 5
RxNorm normalized name: Toltrazuril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toltrazuril 5 % suspension (Baycox®, Bayer)
Trial: 8862223
Drug: Urinary albumin
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary albumin excretion (UAE)
Trial: 7013056
Drug: Levamisole 100
RxNorm normalized name: Levamisole
DrugBank: Levamisole (DB00848)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levamisole 100 mg
Trial: 10200005
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone at 2 mg/kg/dose (maximum 120 mg/dose) twice daily
Trial: 30626424
Drug: Saline (placebo)
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline (placebo) combined with fluoxetine (20 mg/day)
Trial: 10714475
Drug: 10-day clarithromycin
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-day clarithromycin 500 mg bid
Trial: 12369756
Drug: Glimepiride tablet
RxNorm normalized name: Glimepiride Tablets
DrugBank: Glimepiride (DB00222)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glimepiride tablet (1.0 mg)
Trial: 11772908
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 8 mg once daily
Trial: 2769581
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) mean daily intake of 2.44 grams
Trial: 8366819
Drug: Traditional immunization
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional immunization schedule (group B): immunized at 4 days, 1 month, and 6 months of life with 10 micrograms of recombinant HBV vaccine (Engerix B, SKF)
Trial: 9987495
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy (Bakkevold trial)
Trial: 7838635
Drug: Small volume
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small volume feeding (4 mL/kg)
Trial: 9431834
Drug: Salbutamol 8
RxNorm normalized name: Salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol 8 mg
Trial: 2856892
Drug: Nadolol 20
RxNorm normalized name: nadolol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol 20 mg
Trial: 8004841
Drug: Bisoprolol 5
RxNorm normalized name: bisoprolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 5 mg
Trial: 10852450
Drug: ACTH infusion
RxNorm normalized name: ACTH
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ACTH infusion (Cortrosyn, 50 microg/h) in E2-replaced women
Trial: 26843092
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g CLA (75 % c9,t11‐CLA, 87 % purity)
Trial: 21805567
Drug: 6 Fr
RxNorm normalized name: Catheter 16 Fr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 Fr catheters with manual injection
Trial: 2874047
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of salbutamol 0.1 mg/kg followed by inhalation of 0.25 mg of ipratropium bromide
Trial: 2874047
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of ipratropium bromide and salbutamol
Trial: 24089589
Drug: Testosterone Treatment
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone Treatment (TT)
Trial: 30537937
Drug: BEATVIC therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BEATVIC therapy (body-oriented resilience therapy using kickboxing exercises)
Trial: 11583479
Drug: Etoricoxib 120
RxNorm normalized name: etoricoxib 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib 120 mg
Trial: 12855319
Drug: Ketorolac 10
RxNorm normalized name: ketorolac 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 10 mg q.i.d.
Trial: 10501793
Drug: Calcium 1
RxNorm normalized name: Calcium 10-undecenoate
DrugBank: Calcium undecylenate (DB15678)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 1 g twice daily for 12 months
Trial: 10501793
Drug: Calcium 1
RxNorm normalized name: Calcium 10-undecenoate
DrugBank: Calcium undecylenate (DB15678)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 1 g twice daily for 12 months plus intranasal calcitonin 400 IU/day for the first month and then 200 IU/day for 11 months
Trial: 1835301
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 gel, 0.5 mg
Trial: 1835301
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 gel (meta-analysis)
Trial: 20634186
Drug: Ulipristal acetate
RxNorm normalized name: Ulipristal Acetate
DrugBank: Ulipristal (DB08867)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ulipristal acetate (30 mg, oral)
Trial: 15123461
Drug: Early postoperative
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early postoperative intraperitoneal chemotherapy (EPIC) plus systemic chemotherapy after complete cytoreductive surgery
Trial: 15123461
Drug: Systemic chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic chemotherapy alone after complete cytoreductive surgery
Trial: 25358490
Drug: 900 mg
RxNorm normalized name: diosmin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg of a polyphenol-rich treatment extracted from fruit and vegetables (Mediterranean diet) daily for 12 weeks
Trial: 22937895
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine once daily
Trial: 12106929
Drug: Acetylcholine (ACh)
DrugBank: Acetylcholine (DB03128)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylcholine (ACh) infusion in the IRA after one year
Trial: 16932286
Drug: Intravenous bisphosphonates
RxNorm normalized name: methylene diphosphonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bisphosphonates (currently under investigation)
Trial: 20424456
Drug: Diamorphine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diamorphine treatment
Trial: 27261562
Drug: Disorder-specific Cognitive
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disorder-specific Cognitive Behaviour Therapy (DS‐CBT)
Trial: 21945130
Drug: Buprenorphine transdermal
RxNorm normalized name: Buprenorphine Transdermal System
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Buprenorphine transdermal system (BTDS)
Trial: 30683137
Drug: Propofol (3-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (3-5 mg/kg/h intravenous injection for the duration of surgery)
Trial: 9187591
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate 30 mmol (7.5 g) daily for 3 days
Trial: 15881479
Drug: Moxifloxacin 0.5%
RxNorm normalized name: Moxifloxacin 0.5%, Bromfenac 0.075% Ophthalmic drops, solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 0.5% ophthalmic solution
Trial: 19167587
Drug: Rosiglitazone maleate
RxNorm normalized name: Rosiglitazone Maleate
DrugBank: Rosiglitazone (DB00412)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rosiglitazone maleate (reference formulation)
Trial: 20458090
Drug: Cholecalciferol treatment
RxNorm normalized name: Cholecalciferol
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol treatment (2000 IU/d)
Trial: 27487966
Drug: Nurse-initiated antiviral
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Nurse-initiated antiviral therapy
Trial: 27487966
Drug: Physician-initiated antiviral
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Physician-initiated antiviral therapy
Trial: 8238193
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (0.05 mg/day)
Trial: 1053438
Drug: Betamethasone valerate
RxNorm normalized name: Betamethasone Valerate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone valerate nasal aerosol (400 micrograms daily)
Trial: 23399032
Drug: Physical Activity
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical Activity Promotion Programme (PAPP) for 60 minutes, twice a week during three months
Trial: 22610495
Drug: ACM-to-CC (n=21)
RxNorm normalized name: (+/-)-N-methylephedrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACM-to-CC (n=21)
Trial: 22610495
Drug: CC-to-CC (n=28)
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC-to-CC (n=28)
Trial: 20718174
Drug: Estimated dose
RxNorm normalized name: desmopressin Metered Dose Nasal Spray [Stimate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estimated dose based on gland size
Trial: 14988669
Drug: pegylated interferon
RxNorm normalized name: Pegylated interferon alfa-2a
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: pegylated interferon (considered for future treatment)
Trial: 27190087
Drug: Linagliptin plus
RxNorm normalized name: Linagliptin
DrugBank: Linagliptin (DB08882)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Linagliptin plus pioglitazone 30 mg
Trial: 27190087
Drug: Linagliptin plus
RxNorm normalized name: Linagliptin
DrugBank: Linagliptin (DB08882)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Linagliptin plus pioglitazone 45 mg
Trial: 31713160
Drug: Linagliptin monotherapy
RxNorm normalized name: Linagliptin
DrugBank: Linagliptin (DB08882)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Linagliptin monotherapy
Trial: 22409999
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received insulin if blood glucose >14 mmol/l (n = 8)
Trial: 22409999
Drug: Intravenous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous insulin administration (n = 9)
Trial: 1330437
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitors
Trial: 11345028
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of Ukrain
Trial: 8940324
Drug: Alcohol ingestion
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol ingestion (0.7 g/kg) in women on ERT
Trial: 17905660
Drug: Low-dose mifepristone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose mifepristone
Trial: 12230417
Drug: Hormone use
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone use (first 6 months)
Trial: 12230417
Drug: Estrogen dose
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen dose
Trial: 7606199
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 800 mg/m2/day
Trial: 15506554
Drug: 3.5 mL
RxNorm normalized name: ethanol 3.5 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 mL (26.25 mg) of 0.75% glucose-free ropivacaine
Trial: 15506554
Drug: 4.5 mL
RxNorm normalized name: 4.5 ML Triferic 1.5 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 mL (33.75 mg) of 0.75% glucose-free ropivacaine
Trial: 19226424
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg once daily for 2 years
Trial: 10593430
Drug: Dalteparin once
RxNorm normalized name: dalteparin
DrugBank: Dalteparin (DB06779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin once daily (mean 4631 IU anti-factor Xa units/day)
Trial: 23420115
Drug: Caffeine 200
RxNorm normalized name: caffeine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 200 mg
Trial: 10665784
Drug: Air treatment
RxNorm normalized name: GLYCERIN 3.88 mg in 1 mL TOPICAL SHAMPOO [HAIR TREATMENT PREMIUM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air treatment in 10 fractions (total dose of 40 Gy)
Trial: 9203726
Drug: Oral poliovirus
RxNorm normalized name: poliovirus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral poliovirus vaccine (OPV1, OPV2, OPV3, OPV4)
Trial: 6743447
Drug: morphine sulphate
RxNorm normalized name: Morphine sulphate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: morphine sulphate 2 mg
Trial: 23816491
Drug: Extended release
RxNorm normalized name: Tylenol Extended Release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended release gabapentin (G-ER)
Trial: 22011892
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no additional treatment, filled with vertically condensed gutta-percha)
Trial: 22961865
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (control)
Trial: 25377269
Drug: Ghrelin administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ghrelin administration (0.5 μg/kg/h continuous infusion)
Trial: 19403992
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) 1,800 mg daily